These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 316274)

  • 1. L-5-hydroxytryptophan therapy in myoclonus: discussion.
    Adv Neurol; 1979; 26():117-22. PubMed ID: 316274
    [No Abstract]   [Full Text] [Related]  

  • 2. L-5-hydroxytryptophan therapy in myoclonus.
    Van Woert MH; Rosenbaum D
    Adv Neurol; 1979; 26():107-15. PubMed ID: 316273
    [No Abstract]   [Full Text] [Related]  

  • 3. Myoclonus and L-5-hydroxytryptophan (L-5HTP).
    Van Woert MH
    Prog Clin Biol Res; 1983; 127():43-52. PubMed ID: 6351100
    [No Abstract]   [Full Text] [Related]  

  • 4. [Letter: Combination of a dopa decarboxylase inhibitor with 5-hydroxytryptophan therapy].
    Lhermitte F; Degos CF; Marteau R
    Nouv Presse Med; 1975 Jan; 4(1):31. PubMed ID: 1079935
    [No Abstract]   [Full Text] [Related]  

  • 5. Spinal myoclonus: successful treatment with the combination of sodium valproate and L-5-hydroxytryptophan.
    Jiménez-Jiménez FJ; Roldan A; Zancada F; Molina-Arjona JA; Fernandez-Ballesteros A; Santos J
    Clin Neuropharmacol; 1991 Apr; 14(2):186-90. PubMed ID: 2015615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and metabolic observations on the treatment of myoclonus with L-5-HTP and carbidopa.
    Thal L; Sharpless N; Wolfson L; Engel J; Katzman R
    Trans Am Neurol Assoc; 1976; 101():48-52. PubMed ID: 1088459
    [No Abstract]   [Full Text] [Related]  

  • 7. [Case of intention myoclonus (Lance-Adams syndrome) and a dramatic effect of L-5-hydroxytryptophan].
    Satoyoshi E; Kinoshita M; Takazawa Y; Yoda K
    Rinsho Shinkeigaku; 1976 Sep; 16(9):654-60. PubMed ID: 1087598
    [No Abstract]   [Full Text] [Related]  

  • 8. L-5-hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent.
    Growdon JH; Young RR; Shahani BT
    Neurology; 1976 Dec; 26(12):1135-40. PubMed ID: 1086988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of cherry red spot-myoclonus syndrome with 5-hydroxytryptophan.
    Gascon G; Wallenberg B; Daif AK; Ozand P
    Ann Neurol; 1988 Sep; 24(3):453-5. PubMed ID: 3265864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-5 HTP available under treatment IND.
    FDA Drug Bull; 1983 Aug; 13(2):12-3. PubMed ID: 6604672
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of intravenous L-5-HTP in the myoclonic encephalopathy of infants.
    Gobbi G; Melideo G; Giovanardi Rossi P
    Neuropediatrics; 1986 May; 17(2):63-5. PubMed ID: 3014368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-hypoxic intention myoclonus treated with 5-hydroxy-tryptophan and an extracerebral decarboxylase inhibitor.
    Magnussen I; Dupont E; Engbaek F; de Fine Olivarius B
    Acta Neurol Scand; 1978 Apr; 57(4):289-94. PubMed ID: 307327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myoclonus.
    Marsden CD
    Mod Trends Neurol; 1975; 6():321-2. PubMed ID: 1105145
    [No Abstract]   [Full Text] [Related]  

  • 14. Myoclonus, ataxia, and hypoventilation: response to L-5-hydroxytryptophan.
    Feit H; Kirkpatrick J; Van Woert MH; Pandian G
    Neurology; 1983 Jan; 33(1):109-12. PubMed ID: 6600288
    [No Abstract]   [Full Text] [Related]  

  • 15. [Indications for L-5-hydroxytryptophan in neurology].
    Uldry PA; Regli F
    Rev Med Suisse Romande; 1987 Sep; 107(9):703-7. PubMed ID: 2962265
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Treatment of post-anoxic intention myoclonus.
    Van Woert MH; Sethy VH
    Lancet; 1974 Jun; 1(7869):1285. PubMed ID: 4134164
    [No Abstract]   [Full Text] [Related]  

  • 17. [Utilization of levo-5-hydroxytryptophan in post-anoxic myoclonus].
    Rascol A; Guiraud-Chaumeil B; Laboucarie J; Montastruc JL; El-Hage W
    Therapie; 1978; 33(5):623-8. PubMed ID: 311085
    [No Abstract]   [Full Text] [Related]  

  • 18. Palatal myoclonus treated with 5-hydroxytryptophan and a decarboxylase-inhibitor.
    Magnussen I; Dupont E; Prange-Hansen A; de Fine Olivarius B
    Acta Neurol Scand; 1977 Mar; 55(3):251-53. PubMed ID: 300537
    [No Abstract]   [Full Text] [Related]  

  • 19. Serotonin and myoclonic seizures.
    Munsat TL
    N Engl J Med; 1977 Jan; 296(2):101-2. PubMed ID: 299730
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations.
    Thal LJ; Sharpless NS; Wolfson L; Katzman R
    Ann Neurol; 1980 Jun; 7(6):570-6. PubMed ID: 6969054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.